|
DNA, A-Form
|
G02.111.570.820.486.128 |
|
|
Methylphenidate
|
D03.383.621.460 |
|
|
Encephalitis Virus, St. Louis
|
B04.820.578.344.350.300.330 |
|
|
Serine Peptidase Inhibitors, Kazal Type
|
D12.644.822.750 |
|
|
Nitrogen Fixation
|
G02.607.560.750 |
|
|
Mutant Proteins
|
D12.776.602 |
|
|
Cytochrome-B(5) Reductase
|
D08.811.682.608.191.237 |
|
|
Africa South of the Sahara
|
Z01.058.290 |
|
|
Africa
|
Z01.058 |
|
|
Receptors, Purinergic
|
D12.776.543.750.720.700 |
|
|
Extracorporeal Membrane Oxygenation
|
E04.292.451 |
|
|
Drug Resistance, Multiple, Viral
|
G07.690.773.984.269.420.500 |
|
|
Drug Resistance, Viral
|
G07.690.773.984.269.420 |
|
|
Swimming
|
I03.450.642.845.945.500 |
|
|
Water Sports
|
I03.450.642.845.945 |
|
|
Cholesterol Ester Storage Disease
|
C18.452.648.398.641.201 |
|
|
Tablets, Enteric-Coated
|
D26.255.210.860 |
|
|
Coproporphyrinogen Oxidase
|
D08.811.682.660.250 |
|
|
Carboxypeptidase H
|
D08.811.277.656.675.555.250 |
|
|
Conjunctival Neoplasms
|
C04.588.364.235 |
|
